RNA vs PFE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jan 31, 2026
RNA
62.2
AI Score
VS
PFE Wins
PFE
70.0
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | RNA | PFE | Winner |
|---|---|---|---|
| Revenue | 17.89M | 76.04B | PFE |
| Net Income | -447.53M | 26.38B | PFE |
| Net Margin | -2500.9% | 34.7% | PFE |
| ROE | -23.7% | 28.5% | PFE |
| ROA | -21.0% | 13.5% | PFE |
| Total Assets | 2.13B | 195.35B | PFE |
| Cash | 350.16M | 1.30B | PFE |
| Current Ratio | 11.57 | 1.59 | RNA |
| Free Cash Flow | -488.48M | 18.45B | PFE |
Frequently Asked Questions
Based on our detailed analysis, PFE is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.